Stay updated on Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5 on the page, signaling a minor version update rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-06-09T02:38:45.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page footer shows Revision: v3.5.4, replacing Revision: v3.5.3. This indicates a small update to the page's versioning/documentation rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-05-18T13:38:15.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.0 to v3.5.3, indicating a minor platform/site release without altering the underlying study details.
    Difference
    0.1%
    Check dated 2026-04-27T07:59:43.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0. No visible changes to the study details page were observed.
    Difference
    0.1%
    Check dated 2026-03-22T11:32:05.000Z thumbnail image
  7. Check
    94 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.3 (replacing the previous v3.4.2).
    Difference
    0.1%
    Check dated 2026-03-08T01:52:00.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    No additions or deletions are detected in the provided page context. The page content appears unchanged between screenshots.
    Difference
    0.1%
    Check dated 2026-02-28T19:33:39.000Z thumbnail image

Stay in the know with updates to Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page.